TCT-419 Long-term clinical outcomes of patients presenting with in-stent restenosis after drug-eluting stent implantation for unprotected left main coronary artery. A pooled analysis of the ISAR-LEFT MAIN and ISAR-LEFT MAIN 2 randomized trials

Large randomized clinical trials as well as real world registries lend support to the use of percutaneous treatment of unprotected left main coronary artery (uLMCA) as a valid alternative to CABG in patients with low-intermediate SYNTAX scores. However, long-term clinical outcomes of patients